BRPI0514867A - forma polimórfica de inulina e uso dos mesmos - Google Patents
forma polimórfica de inulina e uso dos mesmosInfo
- Publication number
- BRPI0514867A BRPI0514867A BRPI0514867-7A BRPI0514867A BRPI0514867A BR PI0514867 A BRPI0514867 A BR PI0514867A BR PI0514867 A BRPI0514867 A BR PI0514867A BR PI0514867 A BRPI0514867 A BR PI0514867A
- Authority
- BR
- Brazil
- Prior art keywords
- inulin
- din
- polymorphic form
- compositions
- gin
- Prior art date
Links
- 229920001202 Inulin Polymers 0.000 title abstract 5
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 title abstract 5
- 229940029339 inulin Drugs 0.000 title abstract 5
- 239000000203 mixture Substances 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/733—Fructosans, e.g. inulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0051—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Fructofuranans, e.g. beta-2,6-D-fructofuranan, i.e. levan; Derivatives thereof
- C08B37/0054—Inulin, i.e. beta-2,1-D-fructofuranan; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Polymers & Plastics (AREA)
- Inorganic Chemistry (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Abstract
FORMA POLIMóRFICA DE INULINA E USOS DOS MESMOS A presente invenção refere-se a uma nova forma polimórfica de inulina, designada deita inulina (dIN), a processos para a preparação de dIN, composições compreendendo dIN e seus usos. A presente invenção também refere-se ao uso de dIN e composições compreendendo dIN na preparação de gama inulina (gIN), composições compreendendo gIN e seus usos.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2004905032A AU2004905032A0 (en) | 2004-09-02 | New polymorphic form of particulate inulin | |
| PCT/AU2005/001328 WO2006024100A1 (en) | 2004-09-02 | 2005-09-01 | New polymorphic form of inulin and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0514867A true BRPI0514867A (pt) | 2008-06-24 |
Family
ID=35999639
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0514867-7A BRPI0514867A (pt) | 2004-09-02 | 2005-09-01 | forma polimórfica de inulina e uso dos mesmos |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US9492547B2 (pt) |
| EP (1) | EP1791873B1 (pt) |
| JP (1) | JP5529377B2 (pt) |
| BR (1) | BRPI0514867A (pt) |
| CA (1) | CA2577702C (pt) |
| WO (1) | WO2006024100A1 (pt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2719064C (en) | 2008-04-23 | 2014-02-18 | Kim Martha Jozefa Frooninckx | Aqueous dispersion of fructan-containing particles, method of preparation and use |
| WO2011032229A1 (en) * | 2009-09-18 | 2011-03-24 | Vaxine Pty Ltd | A novel epsilon polymorphic form of inulin and compositions comprising same |
| BR112013032675A2 (pt) * | 2011-06-19 | 2017-08-08 | Vaxine Pty Ltd | composição adjuvante de vacina compreendendo partículas de inulina |
| MX367074B (es) | 2012-01-20 | 2019-08-05 | South Dakota State Univ | Inulina y formulaciones de acetato de inulina. |
| DE102014012717A1 (de) * | 2014-08-27 | 2016-03-03 | Johnson & Johnson Medical Gmbh | Chirurgisches Implantat |
| EP3598128A4 (en) | 2016-12-28 | 2020-12-30 | National Institute of Biomedical Innovation, Healty and Nutrition | PROCESS FOR THE ANALYSIS OF CHARACTERISTICS AND CLASSIFICATION OF PHARMACEUTICAL COMPONENTS USING TRANSCRIPTOMES |
| US11090380B2 (en) | 2018-06-04 | 2021-08-17 | Applied Biotechnology Institute, Inc. | Methods and compositions to increase immune response to vaccines |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0725683B2 (ja) * | 1985-10-31 | 1995-03-22 | ザ オ−ストラリアン ナシヨナル ユニバ−シテイ− | 免疫治療方法 |
| US5422346A (en) | 1988-01-06 | 1995-06-06 | California Natural Products | Instant dried dahlia inulin juice and its method of production and usage |
| CA1337047C (en) | 1988-08-18 | 1995-09-19 | Peter Dodd Cooper | Gamma inulin compositions |
| BR9510202B1 (pt) * | 1994-07-07 | 2009-01-13 | composiÇço de carboidrato polidispersa, processo aplicado a uma soluÇço de composiÇço de carboidrato polidispersa, processo de preparaÇço de uma composiÇço, composiÇço tendo uma estrutura cremosa, composiÇço peletizada e composiÇço cosmÉtica, alimentÍcia e/ou de alimento. | |
| US5840884A (en) * | 1996-03-01 | 1998-11-24 | Kraft Foods, Inc. | Method for controlling crystal morphology of inulin |
-
2005
- 2005-09-01 JP JP2007528526A patent/JP5529377B2/ja not_active Expired - Lifetime
- 2005-09-01 WO PCT/AU2005/001328 patent/WO2006024100A1/en not_active Ceased
- 2005-09-01 BR BRPI0514867-7A patent/BRPI0514867A/pt not_active IP Right Cessation
- 2005-09-01 CA CA2577702A patent/CA2577702C/en not_active Expired - Lifetime
- 2005-09-01 EP EP05775959.9A patent/EP1791873B1/en not_active Expired - Lifetime
- 2005-09-01 US US11/661,667 patent/US9492547B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP1791873B1 (en) | 2014-04-02 |
| CA2577702C (en) | 2014-02-11 |
| US9492547B2 (en) | 2016-11-15 |
| EP1791873A1 (en) | 2007-06-06 |
| CA2577702A1 (en) | 2006-03-09 |
| EP1791873A4 (en) | 2011-09-07 |
| WO2006024100A1 (en) | 2006-03-09 |
| US20090029940A1 (en) | 2009-01-29 |
| JP5529377B2 (ja) | 2014-06-25 |
| JP2008511693A (ja) | 2008-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200970581A1 (ru) | Кристаллическое твёрдое основание разагилина | |
| CL2008001839A1 (es) | Compuestos derivados de 2,7-diazaespirociclos, inhibidores de 11-beta hidroxil esteroide deshidrogenasa tipo 1; composicion farmaceutica que comprende a dichos compuestos; utiles para tratar la obesidad, diabetes, intolerancia a la glucosa, diabetes tipo ii, entre otras enfermedades. | |
| TW200740799A (en) | Alpha2C adrenoreceptor agonists | |
| BRPI0510273A (pt) | derivados de tetraazabenzo[e]azuleno e análogos destes | |
| TNSN07360A1 (en) | Substituted pyrrolo-pyridines, composition containing them, method for their producing and use thereof | |
| BRPI0500393B8 (pt) | forma cristalina ii de agomelatina e sua composição farmacêutica | |
| MX2007008790A (es) | Pirazolo piridinas sustituidas, composiciones que las contienen, metodo de produccion de las mismas, y su uso. | |
| HN2006011218A (es) | Composiciones de tigeciclina y métodos de preparación | |
| MX2007013065A (es) | Derivados de dihidrobenzofurano y usos de los mismos. | |
| CL2004000303A1 (es) | Compuestos derivados de pirimidinas y triazinas; proceso de preparacion; composicion farmaceutica; y su uso para inhibir la replicacion del vih. | |
| BRPI0716495A2 (pt) | (r,r)-fenoterol e análogos de (r,r)- ou (r,s)-fenoterol, uso dos mesmos na preparação de composição farmacêutica e composição farmacêutica compreendendo o referidos compostos. | |
| UA98804C2 (ru) | Катехоламиновые производные и фармацевтическая композиция на их основе | |
| CU23615B7 (es) | Forma cristalina gamma-d del clorhidrato de la ivabradina, su procedimiento de preparación y las composiciones farmacéuticas que las contienen | |
| TW200621313A (en) | Pharmaceutical compositions | |
| GT200600221A (es) | Tigeciclina y metodos de preparacion | |
| GT200600520A (es) | Agentes antibacterianos | |
| MX2016007436A (es) | Composiciones para el cuidado oral que comprenden carbonato de calcio y talco. | |
| WO2012127067A3 (en) | Hydraulic binder composition | |
| TW200745122A (en) | New compounds I | |
| NO20074528L (no) | Substituerte pyrroler, sammensetninger, fremgangsmate for fremstilling og anvendelse av samme | |
| ATE485261T1 (de) | Salicylsäurederivate | |
| EA200701172A1 (ru) | 2-алкокси-3,4,5-тригидроксиалкиламиды, их получение, композиции, их содержащие, и применение | |
| WO2006136580A3 (en) | 2-(phenylamino)benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels | |
| ECSP109874A (es) | Nuevos compuestos 892 | |
| MX2007006042A (es) | Bengamidas que poseen un ciclo caprolactama sustituido, procedimiento de preparacion, composiciones que las contienen y utilizacion. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according art. 34 industrial property law | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law | ||
| B08F | Application fees: dismissal - article 86 of industrial property law | ||
| B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) |